nodes	percent_of_prediction	percent_of_DWPC	metapath
Midazolam—CYP2E1—liver cancer	0.438	1	CbGaD
Midazolam—CYP3A7—Sorafenib—liver cancer	0.0523	0.181	CbGbCtD
Midazolam—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.0523	0.181	CbGbCtD
Midazolam—CYP2B6—Sorafenib—liver cancer	0.0498	0.172	CbGbCtD
Midazolam—CYP3A5—Sorafenib—liver cancer	0.0392	0.136	CbGbCtD
Midazolam—CYP2B6—Doxorubicin—liver cancer	0.0302	0.104	CbGbCtD
Midazolam—ABCB1—Sorafenib—liver cancer	0.0255	0.0882	CbGbCtD
Midazolam—ABCB1—Doxorubicin—liver cancer	0.0155	0.0535	CbGbCtD
Midazolam—CYP3A4—Sorafenib—liver cancer	0.0153	0.0529	CbGbCtD
Midazolam—CYP3A4—Doxorubicin—liver cancer	0.00928	0.0321	CbGbCtD
Midazolam—Haematoma—Sorafenib—liver cancer	0.00236	0.029	CcSEcCtD
Midazolam—Rhinorrhoea—Sorafenib—liver cancer	0.00183	0.0225	CcSEcCtD
Midazolam—Dysphonia—Sorafenib—liver cancer	0.0018	0.0222	CcSEcCtD
Midazolam—Warmth—Epirubicin—liver cancer	0.00172	0.0212	CcSEcCtD
Midazolam—Warmth—Doxorubicin—liver cancer	0.0016	0.0196	CcSEcCtD
Midazolam—Skin necrosis—Epirubicin—liver cancer	0.00157	0.0193	CcSEcCtD
Midazolam—Skin necrosis—Doxorubicin—liver cancer	0.00145	0.0179	CcSEcCtD
Midazolam—Skin exfoliation—Sorafenib—liver cancer	0.00142	0.0174	CcSEcCtD
Midazolam—Clonazepam—NAT2—liver cancer	0.0013	0.438	CrCbGaD
Midazolam—Cardiac failure—Sorafenib—liver cancer	0.0011	0.0136	CcSEcCtD
Midazolam—Mood swings—Sorafenib—liver cancer	0.00102	0.0125	CcSEcCtD
Midazolam—Local reaction—Epirubicin—liver cancer	0.00099	0.0122	CcSEcCtD
Midazolam—Nasopharyngitis—Sorafenib—liver cancer	0.000963	0.0118	CcSEcCtD
Midazolam—Local reaction—Doxorubicin—liver cancer	0.000916	0.0113	CcSEcCtD
Midazolam—Neuropathy peripheral—Sorafenib—liver cancer	0.000814	0.01	CcSEcCtD
Midazolam—Redness—Epirubicin—liver cancer	0.000812	0.00999	CcSEcCtD
Midazolam—Hyperventilation—Epirubicin—liver cancer	0.000797	0.0098	CcSEcCtD
Midazolam—Thrombosis—Epirubicin—liver cancer	0.000775	0.00953	CcSEcCtD
Midazolam—Nystagmus—Epirubicin—liver cancer	0.000768	0.00944	CcSEcCtD
Midazolam—Redness—Doxorubicin—liver cancer	0.000752	0.00924	CcSEcCtD
Midazolam—Hyperventilation—Doxorubicin—liver cancer	0.000737	0.00907	CcSEcCtD
Midazolam—Connective tissue disorder—Sorafenib—liver cancer	0.000732	0.00901	CcSEcCtD
Midazolam—Thrombosis—Doxorubicin—liver cancer	0.000717	0.00882	CcSEcCtD
Midazolam—Nystagmus—Doxorubicin—liver cancer	0.00071	0.00874	CcSEcCtD
Midazolam—Feeling hot—Epirubicin—liver cancer	0.000699	0.00859	CcSEcCtD
Midazolam—Cardiac disorder—Sorafenib—liver cancer	0.000691	0.0085	CcSEcCtD
Midazolam—Immune system disorder—Sorafenib—liver cancer	0.000673	0.00828	CcSEcCtD
Midazolam—Injection site pain—Epirubicin—liver cancer	0.000672	0.00826	CcSEcCtD
Midazolam—Mediastinal disorder—Sorafenib—liver cancer	0.000671	0.00826	CcSEcCtD
Midazolam—Dysphonia—Epirubicin—liver cancer	0.000666	0.0082	CcSEcCtD
Midazolam—Mental disorder—Sorafenib—liver cancer	0.000653	0.00803	CcSEcCtD
Midazolam—Erythema—Sorafenib—liver cancer	0.000649	0.00798	CcSEcCtD
Midazolam—Feeling hot—Doxorubicin—liver cancer	0.000646	0.00795	CcSEcCtD
Midazolam—Delirium—Epirubicin—liver cancer	0.000637	0.00784	CcSEcCtD
Midazolam—Injection site pain—Doxorubicin—liver cancer	0.000621	0.00764	CcSEcCtD
Midazolam—Dysphonia—Doxorubicin—liver cancer	0.000617	0.00758	CcSEcCtD
Midazolam—Ventricular extrasystoles—Epirubicin—liver cancer	0.000607	0.00747	CcSEcCtD
Midazolam—Delirium—Doxorubicin—liver cancer	0.00059	0.00725	CcSEcCtD
Midazolam—Dyskinesia—Epirubicin—liver cancer	0.000583	0.00718	CcSEcCtD
Midazolam—Syncope—Sorafenib—liver cancer	0.000582	0.00715	CcSEcCtD
Midazolam—Dysarthria—Epirubicin—liver cancer	0.00058	0.00713	CcSEcCtD
Midazolam—Cough—Sorafenib—liver cancer	0.000566	0.00696	CcSEcCtD
Midazolam—Ventricular extrasystoles—Doxorubicin—liver cancer	0.000562	0.00691	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000548	0.00674	CcSEcCtD
Midazolam—Hiccups—Epirubicin—liver cancer	0.000548	0.00674	CcSEcCtD
Midazolam—Ventricular tachycardia—Epirubicin—liver cancer	0.000548	0.00674	CcSEcCtD
Midazolam—Dry mouth—Sorafenib—liver cancer	0.00054	0.00664	CcSEcCtD
Midazolam—Dyskinesia—Doxorubicin—liver cancer	0.00054	0.00664	CcSEcCtD
Midazolam—Dysarthria—Doxorubicin—liver cancer	0.000536	0.0066	CcSEcCtD
Midazolam—Salivary hypersecretion—Epirubicin—liver cancer	0.000533	0.00655	CcSEcCtD
Midazolam—Anaphylactic shock—Sorafenib—liver cancer	0.000529	0.00651	CcSEcCtD
Midazolam—Skin exfoliation—Epirubicin—liver cancer	0.000523	0.00644	CcSEcCtD
Midazolam—Shock—Sorafenib—liver cancer	0.000521	0.00641	CcSEcCtD
Midazolam—Nervous system disorder—Sorafenib—liver cancer	0.000519	0.00638	CcSEcCtD
Midazolam—Skin disorder—Sorafenib—liver cancer	0.000514	0.00632	CcSEcCtD
Midazolam—Ventricular tachycardia—Doxorubicin—liver cancer	0.000507	0.00624	CcSEcCtD
Midazolam—Hiccups—Doxorubicin—liver cancer	0.000507	0.00624	CcSEcCtD
Midazolam—Salivary hypersecretion—Doxorubicin—liver cancer	0.000493	0.00606	CcSEcCtD
Midazolam—Skin exfoliation—Doxorubicin—liver cancer	0.000484	0.00596	CcSEcCtD
Midazolam—Dyspnoea—Sorafenib—liver cancer	0.000472	0.0058	CcSEcCtD
Midazolam—Dyspepsia—Sorafenib—liver cancer	0.000466	0.00573	CcSEcCtD
Midazolam—Phlebitis—Epirubicin—liver cancer	0.000462	0.00568	CcSEcCtD
Midazolam—Thrombophlebitis—Epirubicin—liver cancer	0.00046	0.00566	CcSEcCtD
Midazolam—Gastrointestinal disorder—Sorafenib—liver cancer	0.000457	0.00562	CcSEcCtD
Midazolam—Fatigue—Sorafenib—liver cancer	0.000456	0.00561	CcSEcCtD
Midazolam—Pain—Sorafenib—liver cancer	0.000453	0.00557	CcSEcCtD
Midazolam—Constipation—Sorafenib—liver cancer	0.000453	0.00557	CcSEcCtD
Midazolam—Phlebitis—Doxorubicin—liver cancer	0.000427	0.00526	CcSEcCtD
Midazolam—Thrombophlebitis—Doxorubicin—liver cancer	0.000425	0.00523	CcSEcCtD
Midazolam—Urticaria—Sorafenib—liver cancer	0.000421	0.00517	CcSEcCtD
Midazolam—Anaphylactoid reaction—Epirubicin—liver cancer	0.000411	0.00506	CcSEcCtD
Midazolam—Cardiac failure—Epirubicin—liver cancer	0.000408	0.00502	CcSEcCtD
Midazolam—Lethargy—Epirubicin—liver cancer	0.000406	0.005	CcSEcCtD
Midazolam—Osteoarthritis—Epirubicin—liver cancer	0.000398	0.0049	CcSEcCtD
Midazolam—Diplopia—Epirubicin—liver cancer	0.000398	0.0049	CcSEcCtD
Midazolam—Affect lability—Epirubicin—liver cancer	0.000392	0.00482	CcSEcCtD
Midazolam—Hypersensitivity—Sorafenib—liver cancer	0.00039	0.0048	CcSEcCtD
Midazolam—Anaphylactoid reaction—Doxorubicin—liver cancer	0.000381	0.00468	CcSEcCtD
Midazolam—Asthenia—Sorafenib—liver cancer	0.00038	0.00467	CcSEcCtD
Midazolam—Cardiac arrest—Epirubicin—liver cancer	0.000378	0.00465	CcSEcCtD
Midazolam—Cardiac failure—Doxorubicin—liver cancer	0.000377	0.00464	CcSEcCtD
Midazolam—Mood swings—Epirubicin—liver cancer	0.000377	0.00464	CcSEcCtD
Midazolam—Lethargy—Doxorubicin—liver cancer	0.000376	0.00462	CcSEcCtD
Midazolam—Clonazepam—CYP2E1—liver cancer	0.000375	0.126	CrCbGaD
Midazolam—Pruritus—Sorafenib—liver cancer	0.000374	0.00461	CcSEcCtD
Midazolam—Ataxia—Epirubicin—liver cancer	0.000374	0.0046	CcSEcCtD
Midazolam—Diplopia—Doxorubicin—liver cancer	0.000368	0.00453	CcSEcCtD
Midazolam—Osteoarthritis—Doxorubicin—liver cancer	0.000368	0.00453	CcSEcCtD
Midazolam—Affect lability—Doxorubicin—liver cancer	0.000362	0.00446	CcSEcCtD
Midazolam—Nasopharyngitis—Epirubicin—liver cancer	0.000356	0.00438	CcSEcCtD
Midazolam—Muscular weakness—Epirubicin—liver cancer	0.000351	0.00432	CcSEcCtD
Midazolam—Cardiac arrest—Doxorubicin—liver cancer	0.00035	0.00431	CcSEcCtD
Midazolam—Dizziness—Sorafenib—liver cancer	0.00035	0.00431	CcSEcCtD
Midazolam—Mood swings—Doxorubicin—liver cancer	0.000349	0.00429	CcSEcCtD
Midazolam—Ataxia—Doxorubicin—liver cancer	0.000346	0.00426	CcSEcCtD
Midazolam—Vomiting—Sorafenib—liver cancer	0.000337	0.00414	CcSEcCtD
Midazolam—Rash—Sorafenib—liver cancer	0.000334	0.00411	CcSEcCtD
Midazolam—Dermatitis—Sorafenib—liver cancer	0.000333	0.0041	CcSEcCtD
Midazolam—Headache—Sorafenib—liver cancer	0.000332	0.00408	CcSEcCtD
Midazolam—Nasopharyngitis—Doxorubicin—liver cancer	0.000329	0.00405	CcSEcCtD
Midazolam—Muscular weakness—Doxorubicin—liver cancer	0.000325	0.004	CcSEcCtD
Midazolam—Nausea—Sorafenib—liver cancer	0.000314	0.00387	CcSEcCtD
Midazolam—Drowsiness—Epirubicin—liver cancer	0.000307	0.00377	CcSEcCtD
Midazolam—Flunitrazepam—CYP2E1—liver cancer	0.000301	0.101	CrCbGaD
Midazolam—Neuropathy peripheral—Epirubicin—liver cancer	0.000301	0.0037	CcSEcCtD
Midazolam—Drowsiness—Doxorubicin—liver cancer	0.000284	0.00349	CcSEcCtD
Midazolam—Bradycardia—Epirubicin—liver cancer	0.00028	0.00345	CcSEcCtD
Midazolam—Neuropathy peripheral—Doxorubicin—liver cancer	0.000278	0.00342	CcSEcCtD
Midazolam—Connective tissue disorder—Epirubicin—liver cancer	0.000271	0.00333	CcSEcCtD
Midazolam—Visual impairment—Epirubicin—liver cancer	0.000265	0.00326	CcSEcCtD
Midazolam—Bradycardia—Doxorubicin—liver cancer	0.000259	0.00319	CcSEcCtD
Midazolam—Eye disorder—Epirubicin—liver cancer	0.000257	0.00316	CcSEcCtD
Midazolam—Cardiac disorder—Epirubicin—liver cancer	0.000256	0.00314	CcSEcCtD
Midazolam—Ketazolam—ALB—liver cancer	0.000255	0.0857	CrCbGaD
Midazolam—Connective tissue disorder—Doxorubicin—liver cancer	0.00025	0.00308	CcSEcCtD
Midazolam—Immune system disorder—Epirubicin—liver cancer	0.000249	0.00306	CcSEcCtD
Midazolam—Mediastinal disorder—Epirubicin—liver cancer	0.000248	0.00305	CcSEcCtD
Midazolam—Chills—Epirubicin—liver cancer	0.000247	0.00304	CcSEcCtD
Midazolam—Visual impairment—Doxorubicin—liver cancer	0.000246	0.00302	CcSEcCtD
Midazolam—Flurazepam—CYP2E1—liver cancer	0.000241	0.0811	CrCbGaD
Midazolam—Mental disorder—Epirubicin—liver cancer	0.000241	0.00297	CcSEcCtD
Midazolam—Erythema—Epirubicin—liver cancer	0.00024	0.00295	CcSEcCtD
Midazolam—Eye disorder—Doxorubicin—liver cancer	0.000238	0.00293	CcSEcCtD
Midazolam—Cardiac disorder—Doxorubicin—liver cancer	0.000236	0.00291	CcSEcCtD
Midazolam—Tension—Epirubicin—liver cancer	0.000235	0.00289	CcSEcCtD
Midazolam—Nervousness—Epirubicin—liver cancer	0.000233	0.00286	CcSEcCtD
Midazolam—Immune system disorder—Doxorubicin—liver cancer	0.00023	0.00283	CcSEcCtD
Midazolam—Mediastinal disorder—Doxorubicin—liver cancer	0.00023	0.00282	CcSEcCtD
Midazolam—Chills—Doxorubicin—liver cancer	0.000229	0.00281	CcSEcCtD
Midazolam—Vision blurred—Epirubicin—liver cancer	0.000226	0.00278	CcSEcCtD
Midazolam—Mental disorder—Doxorubicin—liver cancer	0.000223	0.00275	CcSEcCtD
Midazolam—Erythema—Doxorubicin—liver cancer	0.000222	0.00273	CcSEcCtD
Midazolam—Agitation—Epirubicin—liver cancer	0.00022	0.00271	CcSEcCtD
Midazolam—Tension—Doxorubicin—liver cancer	0.000218	0.00268	CcSEcCtD
Midazolam—Nervousness—Doxorubicin—liver cancer	0.000215	0.00265	CcSEcCtD
Midazolam—Vertigo—Epirubicin—liver cancer	0.000215	0.00265	CcSEcCtD
Midazolam—Syncope—Epirubicin—liver cancer	0.000215	0.00264	CcSEcCtD
Midazolam—Cough—Epirubicin—liver cancer	0.000209	0.00257	CcSEcCtD
Midazolam—Vision blurred—Doxorubicin—liver cancer	0.000209	0.00257	CcSEcCtD
Midazolam—Clonazepam—ALB—liver cancer	0.000206	0.0691	CrCbGaD
Midazolam—Agitation—Doxorubicin—liver cancer	0.000204	0.00251	CcSEcCtD
Midazolam—Anxiety—Epirubicin—liver cancer	0.000203	0.0025	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000203	0.00249	CcSEcCtD
Midazolam—Dry mouth—Epirubicin—liver cancer	0.0002	0.00245	CcSEcCtD
Midazolam—Vertigo—Doxorubicin—liver cancer	0.000199	0.00245	CcSEcCtD
Midazolam—Syncope—Doxorubicin—liver cancer	0.000199	0.00245	CcSEcCtD
Midazolam—Confusional state—Epirubicin—liver cancer	0.000197	0.00243	CcSEcCtD
Midazolam—Anaphylactic shock—Epirubicin—liver cancer	0.000196	0.00241	CcSEcCtD
Midazolam—Cough—Doxorubicin—liver cancer	0.000194	0.00238	CcSEcCtD
Midazolam—Shock—Epirubicin—liver cancer	0.000192	0.00237	CcSEcCtD
Midazolam—Nervous system disorder—Epirubicin—liver cancer	0.000192	0.00236	CcSEcCtD
Midazolam—Diazepam—CYP2E1—liver cancer	0.000192	0.0644	CrCbGaD
Midazolam—Tachycardia—Epirubicin—liver cancer	0.000191	0.00235	CcSEcCtD
Midazolam—Skin disorder—Epirubicin—liver cancer	0.00019	0.00234	CcSEcCtD
Midazolam—Anxiety—Doxorubicin—liver cancer	0.000188	0.00231	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000188	0.00231	CcSEcCtD
Midazolam—Dry mouth—Doxorubicin—liver cancer	0.000185	0.00227	CcSEcCtD
Midazolam—Hypotension—Epirubicin—liver cancer	0.000183	0.00225	CcSEcCtD
Midazolam—Confusional state—Doxorubicin—liver cancer	0.000183	0.00224	CcSEcCtD
Midazolam—Anaphylactic shock—Doxorubicin—liver cancer	0.000181	0.00223	CcSEcCtD
Midazolam—Shock—Doxorubicin—liver cancer	0.000178	0.00219	CcSEcCtD
Midazolam—Nervous system disorder—Doxorubicin—liver cancer	0.000178	0.00218	CcSEcCtD
Midazolam—Tachycardia—Doxorubicin—liver cancer	0.000177	0.00217	CcSEcCtD
Midazolam—Skin disorder—Doxorubicin—liver cancer	0.000176	0.00216	CcSEcCtD
Midazolam—Paraesthesia—Epirubicin—liver cancer	0.000176	0.00216	CcSEcCtD
Midazolam—Dyspnoea—Epirubicin—liver cancer	0.000174	0.00215	CcSEcCtD
Midazolam—Somnolence—Epirubicin—liver cancer	0.000174	0.00214	CcSEcCtD
Midazolam—Dyspepsia—Epirubicin—liver cancer	0.000172	0.00212	CcSEcCtD
Midazolam—Hypotension—Doxorubicin—liver cancer	0.000169	0.00208	CcSEcCtD
Midazolam—Gastrointestinal disorder—Epirubicin—liver cancer	0.000169	0.00208	CcSEcCtD
Midazolam—Fatigue—Epirubicin—liver cancer	0.000169	0.00207	CcSEcCtD
Midazolam—Pain—Epirubicin—liver cancer	0.000167	0.00206	CcSEcCtD
Midazolam—Constipation—Epirubicin—liver cancer	0.000167	0.00206	CcSEcCtD
Midazolam—Paraesthesia—Doxorubicin—liver cancer	0.000163	0.002	CcSEcCtD
Midazolam—Dyspnoea—Doxorubicin—liver cancer	0.000161	0.00198	CcSEcCtD
Midazolam—Feeling abnormal—Epirubicin—liver cancer	0.000161	0.00198	CcSEcCtD
Midazolam—Somnolence—Doxorubicin—liver cancer	0.000161	0.00198	CcSEcCtD
Midazolam—Dyspepsia—Doxorubicin—liver cancer	0.000159	0.00196	CcSEcCtD
Midazolam—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000156	0.00192	CcSEcCtD
Midazolam—Fatigue—Doxorubicin—liver cancer	0.000156	0.00192	CcSEcCtD
Midazolam—Urticaria—Epirubicin—liver cancer	0.000155	0.00191	CcSEcCtD
Midazolam—Pain—Doxorubicin—liver cancer	0.000155	0.0019	CcSEcCtD
Midazolam—Constipation—Doxorubicin—liver cancer	0.000155	0.0019	CcSEcCtD
Midazolam—Feeling abnormal—Doxorubicin—liver cancer	0.000149	0.00183	CcSEcCtD
Midazolam—Hypersensitivity—Epirubicin—liver cancer	0.000144	0.00177	CcSEcCtD
Midazolam—Urticaria—Doxorubicin—liver cancer	0.000144	0.00177	CcSEcCtD
Midazolam—Asthenia—Epirubicin—liver cancer	0.00014	0.00173	CcSEcCtD
Midazolam—Pruritus—Epirubicin—liver cancer	0.000138	0.0017	CcSEcCtD
Midazolam—Hypersensitivity—Doxorubicin—liver cancer	0.000133	0.00164	CcSEcCtD
Midazolam—Asthenia—Doxorubicin—liver cancer	0.00013	0.0016	CcSEcCtD
Midazolam—Dizziness—Epirubicin—liver cancer	0.000129	0.00159	CcSEcCtD
Midazolam—Pruritus—Doxorubicin—liver cancer	0.000128	0.00158	CcSEcCtD
Midazolam—Vomiting—Epirubicin—liver cancer	0.000124	0.00153	CcSEcCtD
Midazolam—Rash—Epirubicin—liver cancer	0.000123	0.00152	CcSEcCtD
Midazolam—Dermatitis—Epirubicin—liver cancer	0.000123	0.00152	CcSEcCtD
Midazolam—Headache—Epirubicin—liver cancer	0.000123	0.00151	CcSEcCtD
Midazolam—Dizziness—Doxorubicin—liver cancer	0.00012	0.00147	CcSEcCtD
Midazolam—Nausea—Epirubicin—liver cancer	0.000116	0.00143	CcSEcCtD
Midazolam—Vomiting—Doxorubicin—liver cancer	0.000115	0.00142	CcSEcCtD
Midazolam—Rash—Doxorubicin—liver cancer	0.000114	0.0014	CcSEcCtD
Midazolam—Dermatitis—Doxorubicin—liver cancer	0.000114	0.0014	CcSEcCtD
Midazolam—Headache—Doxorubicin—liver cancer	0.000113	0.00139	CcSEcCtD
Midazolam—Nausea—Doxorubicin—liver cancer	0.000108	0.00132	CcSEcCtD
Midazolam—Diazepam—ALB—liver cancer	0.000105	0.0354	CrCbGaD
Midazolam—SLC22A1—Metabolism—ALDOB—liver cancer	2.46e-05	0.000131	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PPARA—liver cancer	2.44e-05	0.00013	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—NR1H4—liver cancer	2.44e-05	0.00013	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—ALB—liver cancer	2.43e-05	0.000129	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GSTA3—liver cancer	2.39e-05	0.000127	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—ALB—liver cancer	2.39e-05	0.000127	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—NR1H4—liver cancer	2.39e-05	0.000127	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—NR1H4—liver cancer	2.38e-05	0.000127	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—ALB—liver cancer	2.37e-05	0.000126	CbGpPWpGaD
Midazolam—GABRB2—Neuronal System—HRAS—liver cancer	2.36e-05	0.000125	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GSTA3—liver cancer	2.35e-05	0.000125	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CRABP1—liver cancer	2.34e-05	0.000125	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—PPARA—liver cancer	2.34e-05	0.000125	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GSTA3—liver cancer	2.34e-05	0.000125	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—ALB—liver cancer	2.33e-05	0.000124	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	2.32e-05	0.000124	CbGpPWpGaD
Midazolam—GABRB2—Transmembrane transport of small molecules—RAF1—liver cancer	2.3e-05	0.000122	CbGpPWpGaD
Midazolam—GABRA5—Neuronal System—HRAS—liver cancer	2.29e-05	0.000122	CbGpPWpGaD
Midazolam—GABRA3—Neuronal System—HRAS—liver cancer	2.25e-05	0.00012	CbGpPWpGaD
Midazolam—GABRA5—Transmembrane transport of small molecules—RAF1—liver cancer	2.24e-05	0.000119	CbGpPWpGaD
Midazolam—GABRA2—Neuronal System—HRAS—liver cancer	2.21e-05	0.000118	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—HPGDS—liver cancer	2.2e-05	0.000117	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—RAF1—liver cancer	2.2e-05	0.000117	CbGpPWpGaD
Midazolam—GABRB3—Neuronal System—HRAS—liver cancer	2.2e-05	0.000117	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GSTA4—liver cancer	2.19e-05	0.000117	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—RAF1—liver cancer	2.16e-05	0.000115	CbGpPWpGaD
Midazolam—GABRG2—Neuronal System—HRAS—liver cancer	2.16e-05	0.000115	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GSTA4—liver cancer	2.14e-05	0.000114	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—RAF1—liver cancer	2.14e-05	0.000114	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GSTA4—liver cancer	2.14e-05	0.000114	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GSTA2—liver cancer	2.13e-05	0.000114	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	2.13e-05	0.000113	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—RAF1—liver cancer	2.1e-05	0.000112	CbGpPWpGaD
Midazolam—SLC22A1—Transmission across Chemical Synapses—HRAS—liver cancer	2.1e-05	0.000112	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GSTA2—liver cancer	2.09e-05	0.000111	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PIK3CG—liver cancer	2.09e-05	0.000111	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	2.09e-05	0.000111	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GSTA2—liver cancer	2.09e-05	0.000111	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GSTA1—liver cancer	2.06e-05	0.00011	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—HPGDS—liver cancer	2.05e-05	0.000109	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—NAT2—liver cancer	2.04e-05	0.000108	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—ALB—liver cancer	2.03e-05	0.000108	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	2.03e-05	0.000108	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	2.03e-05	0.000108	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PPARG—liver cancer	2.02e-05	0.000107	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GSTA1—liver cancer	2.02e-05	0.000107	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GSTA1—liver cancer	2.01e-05	0.000107	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	2.01e-05	0.000107	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—NAT2—liver cancer	1.99e-05	0.000106	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—NAT2—liver cancer	1.99e-05	0.000106	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	1.97e-05	0.000105	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PSMD10—liver cancer	1.96e-05	0.000104	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PSMA4—liver cancer	1.96e-05	0.000104	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	1.95e-05	0.000104	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ALDOB—liver cancer	1.95e-05	0.000104	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	1.92e-05	0.000102	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ALDOB—liver cancer	1.91e-05	0.000102	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GOT2—liver cancer	1.91e-05	0.000102	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ALDOB—liver cancer	1.91e-05	0.000102	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—UGDH—liver cancer	1.89e-05	0.000101	CbGpPWpGaD
Midazolam—GABRA1—Neuronal System—HRAS—liver cancer	1.88e-05	0.0001	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CPT1B—liver cancer	1.86e-05	9.91e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GLUL—liver cancer	1.86e-05	9.91e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CRABP1—liver cancer	1.86e-05	9.91e-05	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—RAF1—liver cancer	1.84e-05	9.79e-05	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PIK3CD—liver cancer	1.84e-05	9.78e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PSMD10—liver cancer	1.83e-05	9.71e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PSMA4—liver cancer	1.83e-05	9.71e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CRABP1—liver cancer	1.82e-05	9.7e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CRABP1—liver cancer	1.82e-05	9.68e-05	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—ALB—liver cancer	1.81e-05	9.65e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—NR1H4—liver cancer	1.8e-05	9.56e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CYP2E1—liver cancer	1.79e-05	9.54e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—EPT1—liver cancer	1.78e-05	9.48e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GOT2—liver cancer	1.78e-05	9.45e-05	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	1.77e-05	9.42e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GSTA3—liver cancer	1.77e-05	9.4e-05	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—ALB—liver cancer	1.74e-05	9.26e-05	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	1.7e-05	9.04e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—TAT—liver cancer	1.69e-05	8.98e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CYCS—liver cancer	1.68e-05	8.93e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CYP2E1—liver cancer	1.67e-05	8.88e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GGT1—liver cancer	1.65e-05	8.76e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GOT1—liver cancer	1.65e-05	8.76e-05	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	1.63e-05	8.67e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—HPGDS—liver cancer	1.63e-05	8.66e-05	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	1.63e-05	8.65e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GSTA4—liver cancer	1.62e-05	8.59e-05	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—HRAS—liver cancer	1.61e-05	8.58e-05	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PIK3CB—liver cancer	1.6e-05	8.52e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—HPGDS—liver cancer	1.59e-05	8.48e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—HPGDS—liver cancer	1.59e-05	8.46e-05	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—RAF1—liver cancer	1.57e-05	8.38e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GSTA2—liver cancer	1.57e-05	8.37e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CYCS—liver cancer	1.56e-05	8.31e-05	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—PIK3CA—liver cancer	1.56e-05	8.3e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GGT1—liver cancer	1.53e-05	8.16e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GOT1—liver cancer	1.53e-05	8.16e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GSTA1—liver cancer	1.52e-05	8.08e-05	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	1.52e-05	8.07e-05	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	1.51e-05	8.01e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—NAT2—liver cancer	1.5e-05	7.99e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GSTP1—liver cancer	1.48e-05	7.87e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—HMOX1—liver cancer	1.46e-05	7.76e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PSMA4—liver cancer	1.45e-05	7.72e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PSMD10—liver cancer	1.45e-05	7.72e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ALDOB—liver cancer	1.44e-05	7.66e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PSMD10—liver cancer	1.42e-05	7.56e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PSMA4—liver cancer	1.42e-05	7.56e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PSMD10—liver cancer	1.42e-05	7.54e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PSMA4—liver cancer	1.42e-05	7.54e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GOT2—liver cancer	1.41e-05	7.51e-05	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	1.38e-05	7.36e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GOT2—liver cancer	1.38e-05	7.35e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GOT2—liver cancer	1.38e-05	7.34e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GSTP1—liver cancer	1.38e-05	7.33e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CRABP1—liver cancer	1.37e-05	7.31e-05	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	1.37e-05	7.3e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GSTM1—liver cancer	1.36e-05	7.23e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—HMOX1—liver cancer	1.36e-05	7.22e-05	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	1.34e-05	7.12e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CYP2E1—liver cancer	1.33e-05	7.06e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CYP2E1—liver cancer	1.3e-05	6.9e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CYP1A1—liver cancer	1.29e-05	6.86e-05	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—AKT1—liver cancer	1.27e-05	6.78e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GSTM1—liver cancer	1.27e-05	6.73e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CYCS—liver cancer	1.24e-05	6.6e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GGT1—liver cancer	1.22e-05	6.48e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GOT1—liver cancer	1.22e-05	6.48e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CYCS—liver cancer	1.22e-05	6.47e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CYCS—liver cancer	1.21e-05	6.46e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—MTHFR—liver cancer	1.2e-05	6.39e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—HPGDS—liver cancer	1.2e-05	6.39e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CYP1A1—liver cancer	1.2e-05	6.38e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GOT1—liver cancer	1.19e-05	6.35e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GGT1—liver cancer	1.19e-05	6.35e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GOT1—liver cancer	1.19e-05	6.33e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GGT1—liver cancer	1.19e-05	6.33e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PPARA—liver cancer	1.18e-05	6.27e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GLUL—liver cancer	1.15e-05	6.11e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CPT1B—liver cancer	1.15e-05	6.11e-05	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	1.13e-05	6.01e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—MTHFR—liver cancer	1.12e-05	5.95e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—NR1H4—liver cancer	1.11e-05	5.89e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PPARA—liver cancer	1.1e-05	5.84e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GSTP1—liver cancer	1.09e-05	5.82e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTA3—liver cancer	1.09e-05	5.79e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—HMOX1—liver cancer	1.08e-05	5.74e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GSTP1—liver cancer	1.07e-05	5.7e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PSMD10—liver cancer	1.07e-05	5.69e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PSMA4—liver cancer	1.07e-05	5.69e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GSTP1—liver cancer	1.07e-05	5.69e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—HMOX1—liver cancer	1.06e-05	5.62e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—HMOX1—liver cancer	1.05e-05	5.61e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GOT2—liver cancer	1.04e-05	5.54e-05	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	1.02e-05	5.43e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PIK3CG—liver cancer	1.01e-05	5.37e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GSTM1—liver cancer	1.01e-05	5.35e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTA4—liver cancer	9.95e-06	5.29e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GSTM1—liver cancer	9.85e-06	5.24e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GSTM1—liver cancer	9.83e-06	5.23e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYP2E1—liver cancer	9.79e-06	5.21e-05	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PIK3CA—liver cancer	9.76e-06	5.19e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PPARG—liver cancer	9.74e-06	5.18e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTA2—liver cancer	9.7e-06	5.16e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CYP1A1—liver cancer	9.53e-06	5.07e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PIK3CG—liver cancer	9.4e-06	5e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTA1—liver cancer	9.36e-06	4.98e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CYP1A1—liver cancer	9.34e-06	4.97e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CYP1A1—liver cancer	9.32e-06	4.96e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—NAT2—liver cancer	9.25e-06	4.92e-05	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	9.23e-06	4.91e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYCS—liver cancer	9.16e-06	4.87e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PPARG—liver cancer	9.07e-06	4.82e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GOT1—liver cancer	8.98e-06	4.78e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GGT1—liver cancer	8.98e-06	4.78e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—MTHFR—liver cancer	8.89e-06	4.73e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PIK3CD—liver cancer	8.88e-06	4.72e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ALDOB—liver cancer	8.87e-06	4.72e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—ALB—liver cancer	8.76e-06	4.66e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PPARA—liver cancer	8.72e-06	4.64e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—MTHFR—liver cancer	8.7e-06	4.63e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—MTHFR—liver cancer	8.69e-06	4.62e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PPARA—liver cancer	8.54e-06	4.54e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PPARA—liver cancer	8.52e-06	4.53e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CRABP1—liver cancer	8.46e-06	4.5e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PIK3CD—liver cancer	8.26e-06	4.39e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ALB—liver cancer	8.15e-06	4.34e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GSTP1—liver cancer	8.07e-06	4.29e-05	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—AKT1—liver cancer	7.98e-06	4.24e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—HMOX1—liver cancer	7.96e-06	4.23e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PIK3CB—liver cancer	7.74e-06	4.12e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PIK3CG—liver cancer	7.47e-06	3.97e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GSTM1—liver cancer	7.42e-06	3.95e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—HPGDS—liver cancer	7.4e-06	3.93e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PIK3CG—liver cancer	7.31e-06	3.89e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PIK3CG—liver cancer	7.3e-06	3.88e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PPARG—liver cancer	7.21e-06	3.83e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PIK3CB—liver cancer	7.2e-06	3.83e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PPARG—liver cancer	7.06e-06	3.76e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PPARG—liver cancer	7.04e-06	3.75e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYP1A1—liver cancer	7.03e-06	3.74e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PSMA4—liver cancer	6.59e-06	3.51e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PSMD10—liver cancer	6.59e-06	3.51e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PIK3CD—liver cancer	6.56e-06	3.49e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—MTHFR—liver cancer	6.55e-06	3.49e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ALB—liver cancer	6.48e-06	3.45e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PPARA—liver cancer	6.43e-06	3.42e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PIK3CD—liver cancer	6.43e-06	3.42e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PIK3CD—liver cancer	6.42e-06	3.41e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GOT2—liver cancer	6.41e-06	3.41e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ALB—liver cancer	6.35e-06	3.38e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ALB—liver cancer	6.33e-06	3.37e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYP2E1—liver cancer	6.03e-06	3.21e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PIK3CB—liver cancer	5.72e-06	3.04e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYCS—liver cancer	5.64e-06	3e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PIK3CB—liver cancer	5.6e-06	2.98e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PIK3CB—liver cancer	5.59e-06	2.98e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GGT1—liver cancer	5.54e-06	2.94e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GOT1—liver cancer	5.54e-06	2.94e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PIK3CG—liver cancer	5.51e-06	2.93e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PPARG—liver cancer	5.31e-06	2.83e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTP1—liver cancer	4.97e-06	2.65e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—HMOX1—liver cancer	4.9e-06	2.61e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PIK3CD—liver cancer	4.84e-06	2.58e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ALB—liver cancer	4.78e-06	2.54e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PIK3CA—liver cancer	4.72e-06	2.51e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTM1—liver cancer	4.57e-06	2.43e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PIK3CA—liver cancer	4.39e-06	2.33e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYP1A1—liver cancer	4.33e-06	2.3e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PIK3CB—liver cancer	4.22e-06	2.24e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—MTHFR—liver cancer	4.04e-06	2.15e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PPARA—liver cancer	3.96e-06	2.11e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—AKT1—liver cancer	3.85e-06	2.05e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—AKT1—liver cancer	3.59e-06	1.91e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PIK3CA—liver cancer	3.49e-06	1.86e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PIK3CA—liver cancer	3.42e-06	1.82e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PIK3CA—liver cancer	3.41e-06	1.81e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PIK3CG—liver cancer	3.39e-06	1.81e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PPARG—liver cancer	3.27e-06	1.74e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PIK3CD—liver cancer	2.98e-06	1.59e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ALB—liver cancer	2.94e-06	1.57e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—AKT1—liver cancer	2.85e-06	1.52e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—AKT1—liver cancer	2.79e-06	1.48e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—AKT1—liver cancer	2.78e-06	1.48e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PIK3CB—liver cancer	2.6e-06	1.38e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PIK3CA—liver cancer	2.57e-06	1.37e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—AKT1—liver cancer	2.1e-06	1.12e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PIK3CA—liver cancer	1.58e-06	8.43e-06	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—AKT1—liver cancer	1.29e-06	6.89e-06	CbGpPWpGaD
